Library Home | Reset filters
Select one or more filter options and click search below.
Reset filters
AUTHOR(S) Inbal Golan-Tripto; Reuven Tsabari; Elie Picard (et al.)
Since the outbreak of the coronavirus disease 2019 (COVID-19) pandemic, there has been a decline in pediatric emergency department visits. This study aimed to assess the pattern of pediatric foreign body aspiration (FBA) during the first year of the COVID-19 pandemic, in comparison to the prior years. This retrospective multicenter study compared the number of children who presented with FBA during the COVID-19 year (March 1, 2020 to February 28, 2021) to the annual average of the years 2016–2019. It also compared the lockdown periods to the postlockdown periods, and the percentage of missed FBA, proven FBA, and flexible bronchoscopy as the removal procedure.
AUTHOR(S) Henry H. L. Wu; Mohan Shenoy; Philip A. Kalra (et al.)
AUTHOR(S) Konstantine Chakhunasvhili; Davit G. Chakhunashvili; Eka Kvirkvelia (et al.)
In 2019, a new strain of Coronavirus - Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-COV-2) emerged first in China, and then it spread worldwide wreaking havoc on numerous countries and numerous lives. In the pediatric population, disease progression is relatively milder, however, it is of vital importance to gather and analyze the existing data. This study reviewed and gathered data from all the hospitalized patients with Coronavirus Disease 2019 (COVID-19) diagnoses during the period between November 2020 and March 2021. Medical records of 604 children aged between 0-18 years were collected at Children's New Clinic after Irakli Tsitsishvili, which is the biggest pediatric COVID center in Georgia.
AUTHOR(S) Olivier Drouin; Pierre Fontaine; Yann Arnaud (et al.)
Vaccination will be instrumental in controlling the COVID-19 pandemic, and vaccination of children will be necessary to achieve herd immunity. Given that children with chronic health conditions may be at increased risk of COVID-19, it is crucial to understand factors influencing parental decisions about whether to have their child vaccinated. The study objectives were to measure parental intent to have their child with asthma vaccinated against COVID-19 and identify the determinants of their vaccination decision. This study is based on a cross-sectional exploratory observational online survey assessing parents' risk perception in the context of COVID-19.
AUTHOR(S) Robert Whittaker; Margrethe Greve-Isdahl; Håkon Bøås (et al.)
AUTHOR(S) Naifan Duan; Bin Liu; Xiaona Li (et al.)
AUTHOR(S) Jessica Olivia Chereches; Gabriela Ciavoi; Abel Emanuel Moca (et al.)
AUTHOR(S) Ekaterina Pazukhina; Margarita Andreeva; Ekaterina Spiridonova (et al.)
Previous studies assessing the prevalence of COVID-19 sequelae in adults and children were performed in the absence of an agreed definition. This research investigated prevalence of post-COVID-19 condition (PCC) (WHO definition), at 6- and 12-months follow-up, amongst previously hospitalised adults and children and assessed risk factors. Prospective cohort study of children and adults with confirmed COVID-19 in Moscow, hospitalised between April and August, 2020. Two follow-up telephone interviews, using the International Severe Acute Respiratory and Emerging Infection Consortium survey, were performed at 6 and 12 months after discharge.
AUTHOR(S) Zülfikar Akelma; Nevzat Başkaya; Sema Çetin (et al.)
The coronavirus 2019 disease (Covid-19) pandemic led to a number of measures being introduced in many countries worldwide. Lockdowns were imposed on individuals aged <18 years, education was delivered online, and mask-wearing was made compulsory in public places, resulting in an unprecedented period for children. Real-life data showing how children with asthma are affected by major changes are limited. This study investigated how asthmatic children are affected by pandemic conditions based on real-life data. Patients with asthma aged 6–18 years followed up from March to May 2019—before the Covid-19 pandemic—were included in the study. Data from March to May 2020 and 2019 were then compared to reveal the effects of pandemic-related lifestyle changes on symptoms, frequency of exacerbations, and drug use in asthmatic children.
AUTHOR(S) Kristina De Paris; Sallie R. Permar
AUTHOR(S) Maren Johanne Heilskov Rytter
AUTHOR(S) Carolyn A. Chew-Graham; Tracy A. Briggs; Binita Kane
‘Long COVID’ describes both ongoing symptomatic COVID-19 (5–12 weeks after onset) and post-COVID-19 syndrome (≥12 weeks after onset). Long COVID is also a patient-preferred term so will be used throughout this editorial to describe symptoms lasting ≥4 weeks after an acute episode of COVID-19. As the phenomenon of long COVID emerged and came to be recognised, including with the publication of the guideline by the National Institute for Health and Care Excellence, Scottish Intercollegiate Guideline Network, and the Royal College of General Practitioners, there was still limited evidence about whether children and young people could suffer with prolonged symptoms following an acute COVID-19 infection. The general opinion was still that SARS-CoV-2 was a mild infection in the young.
AUTHOR(S) Panagiota Kosmidou; Ioannis Karamatzanis; Sotiris Tzifas (et al.)
COVID-19, caused by SARS-CoV-2, is a highly contagious respiratory tract infection. A major concern of SARS-CoV-2 infection in pregnant women is vertical maternal-fetal transmission and the ramifications on infant hearing. This retrospective study aims to investigate whether perinatal exposure to SARS-CoV-2 has an impact on the hearing of the offspring. The study population included neonates born to unvaccinated COVID-19 positive mothers in the University Hospital of Patras, Greece from March 2020 to January 2021. Polymerase chain reaction (PCR) tests were performed on the neonates on the first, second,, and seventh day of life. All neonates underwent transient evoked otoacoustic emissions (TEOAEs) within the first three months of life and were all examined at the age of nine months.
AUTHOR(S) Gianfranco Trapani; Giuseppe Verlato; Enrico Bertino (et al.)
Long COVID-19 syndrome is a complex of symptoms that occurs after the acute SARS-CoV-2 infection, in the absence of other possible diagnoses. Studies on Long COVID-19 in pediatric population are scanty and heterogeneous in design, inclusion criteria, outcomes, and follow-up time. The objective of the present study is to assess the prevalence of Long COVID-19 syndrome in a cohort of Italian pediatric primary care patients, observed for a period of time of 8 to 36 weeks from healing. Prevalence was also assessed in a cohort of pediatric patients hospitalized during acute infection. Data concerning 629 primary care patients with previous acute SARS-CoV-2 infection were collected by a questionnaire filled in by Primary Care Pediatrician (PCP). The questionnaire was administrated to patients by 18 PCPs based in 8 different Italian regions from June to August 2021. Data concerning 60 hospitalized patients were also collected by consultation of clinical documents.
AUTHOR(S) Zülfikar Akelma; Sema Çetin; Nevzat Başkaya (et al.)
A few studies have already investigated preschool children with asthma during the pandemic. The purpose of this research was to investigate how preschool children with asthma were affected by the precautionary measures adopted during the pandemic. Preschool children with asthma aged 18–60 months evaluated in our clinic in March–May 2019, before the Covid-19 pandemic, were included in the study. The lockdown continued during March, April, and May 2020. The questionnaires and asthma symptom control tests for preschool children with asthma in 2019 and 2020 were then evaluated.
UNICEF Innocenti's Children and COVID-19 Library is a database collecting research from around the world on COVID-19 and its impacts on children and adolescents.
Subscribe to updates on new research about COVID-19 & children
Check our quarterly thematic digests on children and COVID-19
COVID-19 & Children: Rapid Research Response